TMQ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Trilogy Metals Inc (TMQ) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company has strong long-term growth potential driven by its high-grade Arctic project, positive analyst ratings, and potential government support for infrastructure development. While the current technical indicators are neutral, the long-term catalysts and improving financial performance make it a compelling investment opportunity.
The technical indicators show a neutral to slightly bullish trend. The MACD histogram is above 0 and positively contracting, indicating mild bullish momentum. The RSI is neutral at 45.732, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 4.281, R1: 4.632, S1: 3.929, R2: 4.849, S2: 3.712.
The Arctic project is progressing with federal permitting and infrastructure development, supported by potential government financing for the Ambler Road.
Positive economic impact studies and job creation estimates.
Analysts have upgraded the stock with price targets significantly above the current market price, citing a 'catalyst-rich year' in 2026.
The company is still in the development stage with no revenue generation.
Insider and hedge fund trading activity is neutral, indicating no strong institutional support recently.
In Q1 2026, the company reported a net income improvement of 94.95% YoY, with EPS increasing by 100% YoY to -0.04. However, revenue remains at 0, reflecting its development-stage status. The financials show progress in reducing losses, which is a positive sign.
Analysts are bullish on TMQ. Raymond James upgraded the stock to Outperform with a C$8 price target, citing exposure to high-grade copper and potential government support. Freedom Capital initiated coverage with a Buy rating and a $6.20 price target, highlighting the company's strong asset base and re-rating potential. TD Securities also upgraded the stock to Buy, emphasizing a 'catalyst-rich year' in 2026.
